Company profile MDGL
There is not enough data for Madrigal Pharmaceuticals near me to provide analysis
There is not enough data for Madrigal Pharmaceuticals near me to provide correlation calculation
There is not enough data for Madrigal Pharmaceuticals near me to provide analysis
After 39 days of this quarter the interest is at 11.0. Based on that we can calculate that during remaining 52 days it will total up to 26.0. Madrigal Pharmaceuticals stock expected interest is significantly lower compared to previous quarter (-49.0%) and same quarter last year (-83.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 58 | 30 -48.3% QoQ | 33 10.0% QoQ | 21 -36.4% QoQ |
| 2020 | 23 -60.3% YoY 9.5% QoQ | 43 43.3% YoY 87.0% QoQ | 20 -39.4% YoY -53.5% QoQ | 24 14.3% YoY 20.0% QoQ |
| 2021 | 65 182.6% YoY 170.8% QoQ | 33 -23.3% YoY -49.2% QoQ | 17 -15.0% YoY -48.5% QoQ | 17 -29.2% YoY 0.0% QoQ |
| 2022 | 63 -3.1% YoY 270.6% QoQ | 37 12.1% YoY -41.3% QoQ | 33 94.1% YoY -10.8% QoQ | 176 935.3% YoY 433.3% QoQ |
| 2023 | 153 142.9% YoY -13.1% QoQ | 111 200.0% YoY -27.5% QoQ | 140 324.2% YoY 26.1% QoQ | 51 -71.0% YoY -63.6% QoQ |
| 2024 | 11 -92.8% YoY -78.4% QoQ | - | - | - |
The average 5 years interest of Madrigal Pharmaceuticals stock was 4.44 per week. The last year interest of Madrigal Pharmaceuticals stock compared to the last 5 years has changed by 60.59%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 145.86%.
There is not enough data for MDGL login to provide analysis
There is not enough data for MDGL login to provide correlation calculation
There is not enough data for MDGL login to provide analysis
After 39 days of this quarter the interest is at 70.0. Based on that we can calculate that during remaining 52 days it will total up to 163.0. Madrigal Pharmaceuticals news expected interest is significantly higher compared to same quarter last year (+443.3%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 26 | 101 288.5% QoQ | 35 -65.3% QoQ | 84 140.0% QoQ |
| 2020 | 195 650.0% YoY 132.1% QoQ | 286 183.2% YoY 46.7% QoQ | 78 122.9% YoY -72.7% QoQ | 120 42.9% YoY 53.8% QoQ |
| 2021 | 151 -22.6% YoY 25.8% QoQ | 57 -80.1% YoY -62.3% QoQ | 170 117.9% YoY 198.2% QoQ | 159 32.5% YoY -6.5% QoQ |
| 2022 | 150 -0.7% YoY -5.7% QoQ | 123 115.8% YoY -18.0% QoQ | 35 -79.4% YoY -71.5% QoQ | 217 36.5% YoY 520.0% QoQ |
| 2023 | 30 -80.0% YoY -86.2% QoQ | 87 -29.3% YoY 190.0% QoQ | 85 142.9% YoY -2.3% QoQ | 175 -19.4% YoY 105.9% QoQ |
| 2024 | 70 133.3% YoY -60.0% QoQ | - | - | - |
The average 5 years interest of Madrigal Pharmaceuticals news was 9.33 per week. The last year interest of Madrigal Pharmaceuticals news compared to the last 5 years has changed by -7.82%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 31.1%.
There is not enough data for MDGL Phase III clinical trials to provide analysis
There is not enough data for MDGL Phase III clinical trials to provide correlation calculation
There is not enough data for MDGL Phase III clinical trials to provide analysis
There is not enough data for Madrigal Pharmaceuticals resmetirom to provide analysis
There is not enough data for Madrigal Pharmaceuticals resmetirom to provide correlation calculation
There is not enough data for Madrigal Pharmaceuticals resmetirom to provide analysis
There is not enough data for MDGL NASH treatment to provide analysis
There is not enough data for MDGL NASH treatment to provide correlation calculation
There is not enough data for MDGL NASH treatment to provide analysis
There is not enough data for Madrigal Pharmaceuticals MGL-3745 to provide analysis
There is not enough data for Madrigal Pharmaceuticals MGL-3745 to provide correlation calculation
There is not enough data for Madrigal Pharmaceuticals MGL-3745 to provide analysis
There is not enough data for Madrigal Pharmaceuticals corporate governance to provide analysis
There is not enough data for Madrigal Pharmaceuticals corporate governance to provide correlation calculation
There is not enough data for Madrigal Pharmaceuticals corporate governance to provide analysis